South Korea's Pharmaceutical Output Stays Healthy
This article was originally published in PharmAsia News
Executive Summary
SEOUL - The outlook for Korea's pharmaceutical market remains strong with pharmaceutical production rising 9.25 percent in 2008 to KRW13.76 trillion ($12.47 billion) from 2007, Korea FDA reported
You may also be interested in...
Korea Launches Inter-agency Body To Stimulate Local R&D, Earmarks $440 Million For Program
SEOUL - The Korean government has set up an inter-ministry team to support local pharmaceutical companies develop globally competitive drugs. The team will offer R&D training for companies looking to diversify their generic pipelines with innovative products as well as some of the start-up cash needed for new R&D programs
Korea Launches Inter-agency Body To Stimulate Local R&D, Earmarks $440 Million For Program
SEOUL - The Korean government has set up an inter-ministry team to support local pharmaceutical companies develop globally competitive drugs. The team will offer R&D training for companies looking to diversify their generic pipelines with innovative products as well as some of the start-up cash needed for new R&D programs
South Korea Health Ministry Seeks New Drug Reimbursement Pricing System
SEOUL - South Korea's health ministry has assigned a special task force to review the country's drug reimbursement pricing system, which is plagued by high costs for generic drugs and fraud linked to incentive rebates paid to doctors and hospitals